MBMarcus W. Bosenberg

Marcus W. Bosenberg

*This is an algorithmically generated author record based on publicly available information.

Marcus W. Bosenberg has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterization of melanocyte‐specific inducible Cre recombinase transgenic mice

    by Marcus Bosenberg, Viswanathan Muthusamy, David P. Curley, Zhenxiong Wang, Cara Hobbs, Betsy Nelson, Cristina Nogueira, James W. Horner, Ronald DePinho, Lynda Chin

    Conditional Cre‐mediated recombination has emerged as a robust method of introducing somatic genetic alterations in an organ‐specific manner in the mouse. Here, we generated and characterized mice harboring a 4‐hydroxytamoxifen (OHT)‐inducible Cre recombinase‐estrogen receptor fusion transgene under the control of the melanocyte‐specific tyrosinase promoter, designated Tyr::CreERT2. Cre‐mediated recombination was induced in melanocytes in a spatially and temporally controlled manner upon administration of OHT and was documented in embryonic melanoblasts, follicular bulb melanocytes, dermal dendritic melanocytes, epidermal melanocytes of tail skin, and in putative melanocyte stem cells located within the follicular bulge. Functional evidence suggestive of recombination in follicular melanocyte stem cells included the presence of Cre‐mediated recombination in follicular bulb melanocytes 1 year after topical OHT administration, by which time several hair cycles have elapsed and the melanocytes residing in this location have undergone multiple rounds of apoptosis and replenishment. These Tyr:: CreERT2 transgenic mice represent a useful resource for the evaluation of melanocyte developmental genetics, the characterization of melanocyte stem cell function and dynamics, and the construction of refined mouse models of malignant melanoma. genesis 44:262–267, 2006. Published 2006 Wiley‐Liss, Inc.


  • Amplification of CDK4 and MDM2 in malignant melanoma

    by Viswanathan Muthusamy, Cara Hobbs, Cristina Nogueira, Carlos Cordon‐Cardo, Phillip H. McKee, Lynda Chin, Marcus W. Bosenberg

    Amplification of the 12q13–15 region is a common event in several human tumors including liposarcomas, gliomas, and osteosarcomas. We have demonstrated high‐level amplification of 12q14 in a subset of uncultured malignant melanomas (3 of 53). High‐resolution mapping of the amplicon using quantitative PCR revealed a bipartite amplicon consisting of a primary 50‐kb amplicon centered on CDK4 and a secondary amplicon centered on MDM2, without amplification of the intervening 11 Mb of genomic DNA. Analysis of mRNA and protein levels in melanomas with 12q14 amplification demonstrated overexpression of target genes CDK4 and MDM2 without loss of CDKN2A‐P16 (P16INK4A) or CDKN2A‐P14ARF (P14ARF) expression, important regulators of the RB1 and TP53 pathways, which are commonly lost or mutated in melanoma. These results suggest that coamplification of CDK4 and MDM2 may substitute for loss of P16INK4A and P14ARF function in a subset of melanomas.